TuHURA BIOSCIENCES, INC./NV Revenue Breakdown
No Revenue Breakdown for HURA on this site yet.
- 2025-12-31: Total revenue $0.00.
- 2024-12-31: Total revenue $0.00.
- 2023-12-31: Total revenue $0.00.
- 2012-06-30: Total revenue $0.00.
Source checked: the stored Revenue Breakdown page for HURA.
Revenue by product
Each year (12 month)
| Fiscal year end | Total revenue |
|---|---|
| 2025-12-31 | $0.00 |
| 2024-12-31 | $0.00 |
| 2023-12-31 | $0.00 |
| 2012-06-30 | $0.00 |
| 2011-06-30 | $0.00 |
Each quarter (3 month)
| Quarter end | Others | Total revenue |
|---|---|---|
| 2026-03-31 | Not split by product $0.00 | $0.00 |
| 2025-12-31 | Not split by product $0.00 | $0.00 |
| 2025-09-30 | Not split by product $0.00 | $0.00 |
| 2025-06-30 | Not split by product $0.00 | $0.00 |
| 2025-03-31 | Not split by product $0.00 | $0.00 |
| 2024-12-31 | Not split by product $0.00 | $0.00 |
| 2024-09-30 | Not split by product $0.00 | $0.00 |
| 2024-06-30 | Not split by product $0.00 | $0.00 |
| 2024-03-31 | Not split by product $0.00 | $0.00 |
| 2012-12-31 | Not split by product $0.00 | $0.00 |
| 2012-09-30 | Not split by product $0.00 | $0.00 |
| 2012-06-30 | Not split by product $0.00 | $0.00 |
| 2012-03-31 | Not split by product $0.00 | $0.00 |
| 2011-12-31 | Not split by product $0.00 | $0.00 |
| 2011-09-30 | Not split by product $0.00 | $0.00 |
| 2011-06-30 | Not split by product $0.00 | $0.00 |
| 2011-03-31 | Not split by product $0.00 | $0.00 |
| 2010-12-31 | Not split by product $0.00 | $0.00 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |